Currently Viewing:
Currently Reading
Vestibular Migraine Associated With Various Indicators, Comorbidities
March 22, 2019 – Samantha DiGrande
FDA Stops Enrollment in Phase 3 MM Trial Due to 2-Fold Increase in Mortality
March 22, 2019 – Samantha DiGrande
UK Patients, Physicians Feel More Burdened by Myeloproliferative Neoplasms
March 22, 2019 – Allison Inserro
AJMC® in the Press, March 22, 2019
March 22, 2019 – AJMC Staff
What We're Reading: EHR Oversight; Medicaid Expansion and CRC; Arkansas Work Requirements
March 22, 2019 – AJMC Staff
This Week in Managed Care: March 22, 2019
March 22, 2019
5 Takeaways From the 2019 American College of Cardiology Meeting
March 22, 2019 – Mary Caffrey
Medicaid Work Requirements Could Create Problems for Hospital Finances
March 22, 2019 – Wallace Stephens
What We're Reading: States to Recalibrate Hospital Payments; Mumps Outbreak; Tuberculosis Eradication Plan
March 21, 2019 – AJMC Staff

Vice President's Focus on Moonshot Initiative During Last Year in Office

Surabhi Dangi-Garimella, PhD
Following a personal tragedy, vice president Joe Biden has sworn to dedicate his last year in office to help boost cancer research.
Following a personal tragedy—the loss of his oldest son to brain cancer late last year—vice president Joe Biden has sworn to dedicate his last year in office to help boost cancer research, “Because I know there are Democrats and Republicans on the Hill who share our passion, our passion to silence this deadly disease,” he said in a press briefing last year.

Biden’s staff, meanwhile, have set the wheels in motion, meeting with a group of researchers from the American Association of Cancer Research (AACR) last week to focus on smaller initiatives that stand a chance of getting done within this short time frame of a year. During an 80-minute meeting with AACR scientists, Biden’s top policy staffers said they were interested in things beyond discovery—which takes years of investment—but something else that can be more impactful, according to AACR president Jose Baselga, MD, who spoke with STAT. “They are on a time crunch. They know that there is one year left of his administration. They had a sense of urgency,” Baselga said.

Baselga said in his interview that an issue of interest was to develop a national open-access data-sharing initiative for scientists. This would be similar to what the American Society of Clinical Oncology is trying with its CancerLinQ initiative—a health information technology platform that is being developed to aggregate and analyze real-world cancer data that can provide real-time performance feedback to providers in comparison with their peers; provide real-time clinical decision support; and help providers uncover patterns in patient characteristics, treatments, and outcomes, to improve care.  

The scientists also drew the aides’ attention to the importance of next generation gene sequencing in personalized medicine.

Also present at the meeting was George Demetri, MD, of the Dana-Farber Cancer Institute. He told STAT that Biden’s staff discussed ways to break down silos, and the data-sharing initiative could be an important step in the direction.

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!